Immune Status in Solid Organ Transplantation

Completed

• Conditions: Organ Transplants

• Registration Number: NCT01070901
• Lead Sponsor: Dartmouth-Hitchcock Medical Center

Brief Summary

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-02-17
• Study First Submitted QC: 2010-02-17
• Study First Posted: 2010-02-18
• Study Start: 2010-05
• Primary Completion: 2012-03
• Study Completion: 2012-03
• Status Verified: 2013-02
• Last Update Submitted: 2013-02-04
• Last Update Posted: 2013-02-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Impending kidney transplant
• Age >18
• Able to provide informed consent and comply with the study procedures

Exclusion Criteria

• Age<18
• Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Immune Markers	0, 3, 6, 9, 12 months

Trial Locations

Locations (1)

Dartmouth-Hitchcock Medical Center; 🇺🇸 Lebanon, New Hampshire, United States